Φορτώνει......
Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada
BACKGROUND: Phase ii data are increasingly being used as primary evidence for public reimbursement for oncologic drugs. We compared the frequency of reimbursement recommendations for phase ii and phase iii submissions and assessed for variables associated with a positive or conditional recommendatio...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Multimed Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7606040/ https://ncbi.nlm.nih.gov/pubmed/33173389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.6489 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|